Blood cancer (AML leukaemia)
A study to determine how granulocyte (a type of white blood cell) transfusion helps children with cancer suffering from severe bacterial infection.
Who can joinChildren and adults
Age1–18 years
Kind of studyPhase 2: does it work?
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Last updated on the registry 13 Oct 2025. Please confirm with the hospital that this trial is still taking patients.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Tata Memorial Hospital, MumbaiMumbaiDirections ↗
Registry summary (technical)
A phase II randomised, open label study to determine the efficacy of granulocyte transfusion amongst paediatric cancer patients with carbapenem-resistant gram-negative sepsis
Sponsor: TATA MEMORIAL HOSPITAL
CTRI/2023/02/049667 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 13 Oct 2025 · read by us 5 Nov 2026